WANG Sheng , Ph.D.
Founder, CEO
Dr. WANG Sheng is a renowned scientist and innovator in the field of computational biology and bioinformatics. He holds a Ph.D. in Theoretical Physics from the Chinese Academy of Sciences and a B.S. in Biotechnology from Shanghai Jiao Tong University.
He held key positions at leading research institutions and multinational companies, including the University of Chicago TTIC, KAUST, and Tencent AI Lab, and was responsible for the development and launch of multiple products, with a focus on protein structure prediction and R&D strategy.
Dr. WANG is the core developer of RaptorX, a pioneering protein structure prediction tool, and the project leader of tFold, a cutting-edge platform for de novo protein folding. His groundbreaking work has earned him top rankings in prestigious international competitions, including Continuous Automated Model Evaluation (CAMEO) and Critical Assessment of Structure Prediction (CASP) 12 (2016), 14 (2020), and 15 (2022).
With over 60 publications and 7,500+ citations, Dr. WANG's research has had a significant impact on the scientific community. He is a highly sought-after reviewer for 23 leading journals, including 'Nucleic Acids Research', ‘Bioinformatics’, ‘PROTEINS: Structure, Function, and Bioinformatics’ and ‘Briefings in Bioinformatics’.
In recognition of his exceptional contributions, Dr. WANG has been named one of the World's Top 2% Scientists by Stanford University and a China Intelligent Computing Technology Innovator. He is also a recipient of the Shenzhen Peacock Plan, a prestigious program that attracts high-level talents to the city.
As the Founder and Chief Executive Officer of Orchidlinn, Dr. WANG is dedicated to leveraging his expertise and innovative spirit to drive advancements in computational biology and transform the way we understand and harness the power of proteins.
He held key positions at leading research institutions and multinational companies, including the University of Chicago TTIC, KAUST, and Tencent AI Lab, and was responsible for the development and launch of multiple products, with a focus on protein structure prediction and R&D strategy.
Dr. WANG is the core developer of RaptorX, a pioneering protein structure prediction tool, and the project leader of tFold, a cutting-edge platform for de novo protein folding. His groundbreaking work has earned him top rankings in prestigious international competitions, including Continuous Automated Model Evaluation (CAMEO) and Critical Assessment of Structure Prediction (CASP) 12 (2016), 14 (2020), and 15 (2022).
With over 60 publications and 7,500+ citations, Dr. WANG's research has had a significant impact on the scientific community. He is a highly sought-after reviewer for 23 leading journals, including 'Nucleic Acids Research', ‘Bioinformatics’, ‘PROTEINS: Structure, Function, and Bioinformatics’ and ‘Briefings in Bioinformatics’.
In recognition of his exceptional contributions, Dr. WANG has been named one of the World's Top 2% Scientists by Stanford University and a China Intelligent Computing Technology Innovator. He is also a recipient of the Shenzhen Peacock Plan, a prestigious program that attracts high-level talents to the city.
As the Founder and Chief Executive Officer of Orchidlinn, Dr. WANG is dedicated to leveraging his expertise and innovative spirit to drive advancements in computational biology and transform the way we understand and harness the power of proteins.